James Wilbur - Sep 14, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Commercial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for James Wilbur
Stock symbol: TXG
Transactions as of: Sep 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/16/2022, 05:32 PM
Previous filing: Aug 3, 2022
Next filing: Mar 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Award	$0	+95.8K		$0.00	95.8K	Sep 14, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Award	$0	+240K		$0.00	240K	Sep 14, 2022	Class A Common Stock	240K	$33.67	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 25% of the RSUs vest on the one-year anniversary measured from August 21, 2022, and 1/16th of the RSUs vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	25% of the shares subject to the option vest on the one-year anniversary measured from July 27, 2022, and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person continuing as a service provider through each such date.